Medical Xpress news

Medical Xpress / Mothers' exposure to microbes protects their newborn babies against infection

A multi-center study led by researchers at Cincinnati Children's sheds new light on why some newborns become severely ill from Escherichia coli infection, but others do not. It turns out that most babies are immune because ...

Mar 11, 2026
Medical Xpress / How one flu virus can hamper the immune response to another

Prior exposure to one strain of influenza virus may weaken children's ability to mount an effective antibody response against their subsequent exposure to a different flu strain, according to a study led by Weill Cornell ...

Mar 11, 2026
Medical Xpress / Foreign aid cuts to tuberculosis services could cost families $80 billion worldwide

More than a year after the second Trump administration began dismantling the US Agency for International Development (USAID), the global health consequences of this unprecedented loss in international aid continue to surface. ...

Mar 11, 2026
Medical Xpress / Claims data study ties epilepsy drugs in pregnancy to developmental risks

Findings published by The BMJ reinforce previous research linking use of the antiseizure drug valproate during pregnancy to neurodevelopmental disorders such as ADHD and autism in children, and indicate no substantial risk ...

Mar 11, 2026
Medical Xpress / Safer blood clot treatment: Apixaban beats rivaroxaban in head-to-head comparison

The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban is safer than rivaroxaban, ...

Mar 11, 2026
Medical Xpress / Study finds ALS drug hope via AI and veteran records

A Lawrence Livermore National Laboratory (LLNL)-led team of scientists and computational engineers using one of the largest electronic health record datasets ever assembled for ALS has identified several existing medications ...

Mar 11, 2026
Medical Xpress / Clarifying how ketogenic diets treat epilepsy to guide future therapy development

Published in The Lancet Neurology, a new review from the University of Colorado Anschutz in collaboration with UT Southwestern Medical Center, offers the latest scientific explanations for why ketogenic diets reduce seizures ...

Mar 11, 2026
Medical Xpress / Epstein-Barr virus antibodies can distinguish MS from other neuroinflammatory diseases

The connection between multiple sclerosis and Epstein-Barr virus (EBV) is strengthening, according to a paper published this week in JAMA Neurology by a team of international researchers, including one from the University ...

Mar 11, 2026
Medical Xpress / A workout playlist for your heart? Why musical structure could guide rehab

New findings on how the human heart adapts to expressive music features, like loudness or tempo, could lay the foundations for targeted music-based "exercises" to support heart health. Led by King's College London, the study ...

Mar 11, 2026
Medical Xpress / A new tool to predict physical health risks in young people with psychosis

A new clinic-ready web-based risk prediction tool called PsyMetRiC is now available to forecast the risk of young people with psychosis developing cardiometabolic disorders such as obesity, metabolic syndrome and diabetes.

Mar 11, 2026
Medical Xpress / Dengue vaccine remains 80.5% effective against severe cases after five years

In a phase 3 clinical trial, the tetravalent dengue vaccine, developed by the Butantan Institute in São Paulo, Brazil, was 80.5% effective against severe dengue cases with warning signs over a five-year period. The results ...

Mar 11, 2026
Medical Xpress / New atlas maps aging brain epigenetic shifts across eight regions and 36 cell types

Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to Parkinson's to ALS and beyond, is expected to double every 20 years. Though scientists know aging ...

Mar 11, 2026